Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

BACKGROUND: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil as a topic...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraiva, Maria Isabel Ramos, Portocarrero, Larissa Karine Leite, Vieira, Marcella Amaral Horta Barbosa, Swiczar, Bethania Cabral Cavalli, Westin, Andrezza Telles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2018
Materias:
Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063094/
https://www.ncbi.nlm.nih.gov/pubmed/30066759
http://dx.doi.org/10.1590/abd1806-4841.20186982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063094/
https://www.ncbi.nlm.nih.gov/pubmed/30066759
http://dx.doi.org/10.1590/abd1806-4841.20186982

Ejemplares similares